Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design-Reference-Cited by-同舟云学术

Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design

Published:2008-06-17 Issue:4 Volume:22 Page:313-320
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Valgimigli Marco,Campo Gianluca,de Cesare Nicoletta,Vranckx Pascal,Hamon Martial,Angiolillo Dominick J.,Sabatè Manel,Ferrari Fabrizio,Furgieri Alessandro,Tumscitz Carlo,Repetto Alessandra,Colangelo Salvatore,Meliga Emanuele,Kubbajeh Moh’d,Parrinello Giovanni,Percoco Gianfranco,Ferrari Roberto

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10557-008-6121-z.pdf

Reference51 articles.

1. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986;315:983–9.

2. Keating FK, Whitaker DA, Kabbani SS, Ricci MA, Sobel BE, Schneider DJ. Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis. Am J Cardiol 2004;94:725–8.

3. Massberg S, Schulz C, Gawaz M. Role of platelets in the pathophysiology of acute coronary syndrome. Semin Vasc Med 2003;3:147–62.

4. Tran H, Anand SS. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA 2004;292:1867–74.

5. Sun JZ, Maguire D. How to prevent perioperative myocardial injury: the conundrum continues. Am Heart J 2007;154:1021–8.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High platelet reactivity is a predictor of left ventricular remodelling in patients with acute myocardial infarction;ESC Heart Failure;2022-07-31

2. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases;Pharmacological Reviews;2018-06-20

3. Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications;International Journal of Molecular Sciences;2017-08-18

4. Monitoring Antiplatelet Therapy;Seminars in Thrombosis and Hemostasis;2017-03-06

5. Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation;International Journal of Cardiology;2014-12